日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mutational scanning reveals oncogenic CTNNB1 mutations have diverse effects on signaling

突变扫描揭示致癌性CTNNB1突变对信号传导具有多种影响

Krishna, Anagha; Meynert, Alison; Dolt, Karamjit Singh; Kelder, Martijn; Mesropian, Agavni; Ewing, Ailith; Brouwers, Conny; Claassens, Jill Wc; Linssen, Margot M; Sheraz, Shahida; Taylor, Gillian Ca; Gautier, Philippe; Ferrer-Vaquer, Anna; Grimes, Graeme; Becher, Hannes; Silk, Ryan; Gris-Oliver, Albert; Pinyol, Roser; Semple, Colin A; Kendall, Timothy J; Bird, Thomas Graham; Hadjantonakis, Anna-Katerina; Marsh, Joseph A; Llovet, Josep M; Hohenstein, Peter; Wood, Andrew J; Ozdemir, Derya D

Effective therapeutic targeting of CTNNB1-mutant hepatoblastoma with WNTinib.

WNTinib 可有效靶向治疗 CTNNB1 突变型肝母细胞瘤。

Balaseviciute Ugne, Huguet-Pradell Júlia, Abril-Fornaguera Jordi, Gris-Oliver Albert, Rialdi Alex, Fernández-Martínez Elisa, Montironi Carla, Del Pozo Vanessa, Houghton Peter, Zanatto Laura, Mesropian Agavni, Keraite Ieva, Thung Swan, Armengol Carolina, Sancho-Bru Pau, Guccione Ernesto, Pinyol Roser, Llovet Josep M

Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma

单细胞RNA测序衍生的特征谱定义了晚期肝细胞癌对阿特珠单抗+贝伐珠单抗的反应模式

Cappuyns, Sarah; Piqué-Gili, Marta; Esteban-Fabró, Roger; Philips, Gino; Balaseviciute, Ugne; Pinyol, Roser; Gris-Oliver, Albert; Vandecaveye, Vincent; Abril-Fornaguera, Jordi; Montironi, Carla; Bassaganyas, Laia; Peix, Judit; Zeitlhoefler, Marcus; Mesropian, Agavni; Huguet-Pradell, Júlia; Haber, Philipp K; Figueiredo, Igor; Ioannou, Giorgio; Gonzalez-Kozlova, Edgar; D'Alessio, Antonio; Mohr, Raphael; Meyer, Tim; Lachenmayer, Anja; Marquardt, Jens U; Reeves, Helen L; Edeline, Julien; Finkelmeier, Fabian; Trojan, Jörg; Galle, Peter R; Foerster, Friedrich; Mínguez, Beatriz; Montal, Robert; Gnjatic, Sacha; Pinato, David J; Heikenwalder, Mathias; Verslype, Chris; Van Cutsem, Eric; Lambrechts, Diether; Villanueva, Augusto; Dekervel, Jeroen; Llovet, Josep M

E7386 Enhances Lenvatinib's Antitumor Activity in Preclinical Models and Human Hepatocellular Carcinoma.

E7386 增强了乐伐替尼在临床前模型和人类肝细胞癌中的抗肿瘤活性。

Mesropian Agavni, Gris-Oliver Albert, Balaseviciute Ugne, Potdar Alka A, Kimura Takayuki, Shen Jialing, Torres-Marcén Martí, Abril-Fornaguera Jordi, Piqué-Gili Marta, Camell-Raventos David, Peix Judit, Fernández-Martínez Elisa, Huguet-Pradell Júlia, Hernández de Sande Ana, Keraite Ieva, Esteban-Fabró Roger, Bárcena-Varela Marina, Lindblad Katherine E, Lujambio Amaia, Guccione Ernesto, Thung Swan, Ikeda Masafumi, Kudo Masatoshi, Sia Daniela, Pinyol Roser, Llovet Josep M

Artificial intelligence predicts outcome-related molecular profiles and vascular invasion in hepatocellular carcinoma

人工智能预测肝细胞癌的预后相关分子特征和血管侵犯

Seraphin, Tobias Paul; Mesropian, Agavni; Žigutytė, Laura; Brooks, James; Mauro, Ezequiel; Gris-Oliver, Albert; Pinyol, Roser; Montironi, Carla; Balaseviciute, Ugne; Piqué-Gili, Marta; Huguet-Pradell, Júlia; van Treeck, Marko; Kallenbach, Michael; Schneider, Anne Theres; Roderburg, Christoph; Kather, Jakob Nikolas; Luedde, Tom; Llovet, Josep M

Molecular insights into early malignant transition of hepatocellular carcinoma

肝细胞癌早期恶性转化的分子机制研究

Zhang, Zhengtao; Li, Hong; Chen, Lingli; Lu, Tao; Shentu, Xinyi; Liu, Yuanhua; Ji, Shuyi; Qiu, Zhixin; Zou, Yining; Wen, Hong; Han, Jing; Jiang, Zhengzeng; Fan, Jie; Li, Dianfan; Mesropian, Agavni; Pinyol, Roser; Llovet, Josep M; Dong, Hui; Ji, Yuan; Hui, Lijian

Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC

PMEPA1 的致癌作用及其与肝细胞癌中的免疫衰竭和 TGF-β 激活的关系

Marta Piqué-Gili, Carmen Andreu-Oller, Agavni Mesropian, Roger Esteban-Fabró, Marina Bárcena-Varela, Marina Ruiz de Galarreta, Carla Montironi, Iris Martinez-Quetglas, Sarah Cappuyns, Judit Peix, Ieva Keraite, Albert Gris-Oliver, Elisa Fernández-Martínez, Ezequiel Mauro, Miguel Torres-Martin, Jordi

Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification

肝细胞癌的炎症型和非炎症型:一种修订的免疫基因组学分类

Montironi, Carla; Castet, Florian; Haber, Philipp K; Pinyol, Roser; Torres-Martin, Miguel; Torrens, Laura; Mesropian, Agavni; Wang, Huan; Puigvehi, Marc; Maeda, Miho; Leow, Wei Qiang; Harrod, Elizabeth; Taik, Patricia; Chinburen, Jigjidsuren; Taivanbaatar, Erdenebileg; Chinbold, Enkhbold; Solé Arqués, Manel; Donovan, Michael; Thung, Swan; Neely, Jaclyn; Mazzaferro, Vincenzo; Anderson, Jeffrey; Roayaie, Sasan; Schwartz, Myron; Villanueva, Augusto; Friedman, Scott L; Uzilov, Andrew; Sia, Daniela; Llovet, Josep M

Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

卡博替尼增强抗 PD1 活性并引发肝细胞癌中的中性粒细胞免疫反应

Roger Esteban-Fabró #, Catherine E Willoughby #, Marta Piqué-Gili, Carla Montironi, Jordi Abril-Fornaguera, Judit Peix, Laura Torrens, Agavni Mesropian, Ugne Balaseviciute, Francesc Miró-Mur, Vincenzo Mazzaferro, Roser Pinyol, Josep M Llovet

Immunomodulatory Effects of Lenvatinib Plus Anti-Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma.

乐伐替尼联合抗程序性细胞死亡蛋白 1 在小鼠中的免疫调节作用及肝细胞癌患者富集的理论依据

Torrens Laura, Montironi Carla, Puigvehí Marc, Mesropian Agavni, Leslie Jack, Haber Philipp K, Maeda Miho, Balaseviciute Ugne, Willoughby Catherine E, Abril-Fornaguera Jordi, Piqué-Gili Marta, Torres-Martín Miguel, Peix Judit, Geh Daniel, Ramon-Gil Erik, Saberi Behnam, Friedman Scott L, Mann Derek A, Sia Daniela, Llovet Josep M